sodium phosphate (32P) Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
5036 7635-46-3

Description:

MoleculeDescription

Synonyms:

  • sodium phosphate (32P)
  • disodium hydrogen phosphate (32P)
  • sodium phosphate P-32
  • sodium phosphate P 32
  • phosphotope
  • Molecular weight: 142.96
  • Formula: HNa2O4P
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 83.42
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
March 4, 1959 FDA MALLINCKRODT

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
ATC V10XX01 VARIOUS
THERAPEUTIC RADIOPHARMACEUTICALS
OTHER THERAPEUTIC RADIOPHARMACEUTICALS
Various therapeutic radiopharmaceuticals

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Polycythemia vera indication 109992005

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4018186 VUID
N0000146520 NUI
4018186 VANDF
C0305007 UMLSCUI
CHEMBL2107525 ChEMBL_ID
DB09370 DRUGBANK_ID
71180 PUBCHEM_CID
527 INN_ID
O181101B5G UNII
91559 RXNORM
d04529 MMSL
009990 NDDF

Pharmaceutical products:

None